BCL-2 Inhibitors May Provide Avenue of Attack Against High-Risk Neuroblastoma
April 17th 2017
Investigators at Virginia Commonwealth University Massey Cancer Center discuss the current treatment for children with high-risk neuroblastoma including high-dose chemotherapy, surgery, stem cell transplantation, radiation therapy, isotretinoin, and immunotherapy.